Morgan Stanley
-
-
-
-
-
-
-
Pre-Open 10/17: (LLNW) (NFLX) (AA) Higher (TEUM) (TXT) (IBM) Lower (more...)
-
-
-
-
-
-
-
Morgan Stanley Downgrades Teva Pharma (TEVA) to Equalweight
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised to $20 at Morgan Stanley
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Lowered to $15 at Morgan Stanley
-
-
-
-
-
-
-
UPDATE: Teva Pharma (TEVA) Said to Explore Sale of Women's Health For Up to $2B - Bloomberg
-
-
-
-
-
-
-
Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
-
-
-
-
-
-
-
Notable Analyst Rating Changes 12/7: (ABT) (NSC) (MCC) Upgraded; (CMG) (BLUE) (ARMH) Downgraded
-
158,034 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All